Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Zyflo "homemade" step-down dosing promotional materials cited by FDA in June 27 letter.

Executive Summary

ABBOTT ZYFLO "HOMEMADE" STEP-DOWN DOSING PROMOTIONAL MATERIALS CITED by FDA in a June 27 letter to the company. The Division of Drug Marketing, Advertising, & Communications "has received information about various promotional claims, including unapproved Zyflo [zileuton] dosage regimens (i.e., step-down dosing) and unsubstantiated efficacy claims, allegedly being disseminated by Abbott sales representatives in widely varied geographic areas of the U.S.," FDA told the company.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel